{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:22:07Z","timestamp":1777530127561,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,8,11]],"date-time":"2013-08-11T00:00:00Z","timestamp":1376179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00393-013-1231-9","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T09:00:43Z","timestamp":1376038843000},"page":"910-915","source":"Crossref","is-referenced-by-count":3,"title":["Urologische Begleiterkrankungen bei Patienten mit rheumatoider Arthritis","Urological comorbidities in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"72","author":[{"given":"A.","family":"Friedl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mustak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"H\u00f6ltl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Erlacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,11]]},"reference":[{"key":"1231_CR1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/berh.2002.0257","volume":"16","author":"Symmons","year":"2002","unstructured":"Symmons DP (2002) Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 16(5):707\u2013722","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1231_CR2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/rheumatology\/39.6.603","volume":"39","author":"Young","year":"2000","unstructured":"Young A, Dixey J, Cox N et al (2000) How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology 39(6):603\u2013611","journal-title":"Rheumatology"},{"key":"1231_CR3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0090-4295(01)01130-X","volume":"57","author":"Schilling","year":"2001","unstructured":"Schilling JD, Mulvey MA, Hultgren SJ (2001) Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 57(6 Suppl 1):56\u201361","journal-title":"Urology"},{"key":"1231_CR4","first-page":"27","volume":"50","author":"Morgan","year":"1973","unstructured":"Morgan DM (1973) Urinary tract infection in hospitalized patients. Can Hosp 50(12):27","journal-title":"Can Hosp"},{"key":"1231_CR5","first-page":"511","volume":"255","author":"Schiefer","year":"1983","unstructured":"Schiefer HG, Weidner W, Krauss H et al (1983) Rheumatoid factor-negative arthritis, especially ankylosing spondylitis, and infections of the male urogenital tract. Zentralbl Bakteriol Mikrobiol Hyg A 255(4):511\u2013517","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"key":"1231_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0090-4295(02)01979-9","volume":"60","author":"Schaeffer","year":"2000","unstructured":"Schaeffer AJ et al (2000) Overview summary statement. Diagnosis and management of chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS). Urology 60:1\u20134","journal-title":"Urology"},{"key":"1231_CR7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(06)68071-9","volume":"367","author":"Moe","year":"2006","unstructured":"Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367(9507):333\u2013344","journal-title":"Lancet"},{"key":"1231_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00774-003-0477-8","volume":"22","author":"Incel","year":"2004","unstructured":"Incel NA, Incel N, Nacir B (2004) Bone mineral density and urolithiasis interaction in rheumatoid arthritis. J Bone Miner Metab 22(3):260\u2013263","journal-title":"J Bone Miner Metab"},{"key":"1231_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2474-13-170","volume":"13","author":"Kobelt","year":"2012","unstructured":"Kobelt G, Texier-Richard B (2012) Rheumatoid arthritis and sexuality: a patient survey in France. BMC Musculoskelet Disord 13:170","journal-title":"BMC Musculoskelet Disord"},{"key":"1231_CR10","first-page":"16","volume":"35","author":"Araujo","year":"2010","unstructured":"Araujo DB, Borba EF, Abdo CH et al (2010) Sexual function in rheumatic diseases. Acta Reumatol Port 35(1):16\u201323","journal-title":"Acta Reumatol Port"},{"key":"1231_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10067-006-0216-3","volume":"26","author":"Berlo","year":"2007","unstructured":"Berlo WT van, Wiel HB van de, Taal E et al (2007) Sexual functioning of people with rheumatoid arthritis: a multicenter study. Clin Rheumatol 26(1):30\u201338","journal-title":"Clin Rheumatol"},{"key":"1231_CR12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00296-009-0850-6","volume":"29","author":"Tristano","year":"2009","unstructured":"Tristano AG (2009) The impact of rheumatic diseases on sexual function. Rheumatol Int 29(8):853\u2013860","journal-title":"Rheumatol Int"},{"key":"1231_CR13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/03009740701867349","volume":"37","author":"Helland","year":"2008","unstructured":"Helland Y, Dagfinrud H, Kvien TK (2008) Perceived influence of health status on sexual activity in RA patients: associations with demographic and disease-related variables. Scand J Rheumatol 37(3):194\u2013199","journal-title":"Scand J Rheumatol"},{"key":"1231_CR14","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10067-005-0175-0","volume":"25","author":"Abdel-Nasser","year":"2006","unstructured":"Abdel-Nasser AM, Ali EI (2006) Determinants of sexual disability and dissatisfaction in female patients with rheumatoid arthritis. Clin Rheumatol 25(6):822\u2013830","journal-title":"Clin Rheumatol"},{"key":"1231_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10067-011-1891-2","volume":"31","author":"El","year":"2012","unstructured":"El Miedany Y, El Gaafary M, El Aroussy N et al (2012) Sexual dysfunction in rheumatoid arthritis patients: arthritis and beyond. Clin Rheumatol 31(4):601\u2013606","journal-title":"Clin Rheumatol"},{"key":"1231_CR16","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"Lue","year":"2000","unstructured":"Lue TF (2000) Erectile dysfunction. N Engl J Med 342(24):1802\u20131813","journal-title":"N Engl J Med"},{"key":"1231_CR17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02284057","volume":"7","author":"Blake","year":"1988","unstructured":"Blake DJ, Maisiak R, Koplan A et al (1988) Sexual dysfunction among patients with arthritis. Clin Rheumatol 7(1):50\u201360","journal-title":"Clin Rheumatol"},{"key":"1231_CR18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/anr.1780321029","volume":"32","author":"Blackburn","year":"1989","unstructured":"Blackburn WD Jr, Alarc\u00f3n GS (1989) Impotence in three rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 32(10):1341\u20131342","journal-title":"Arthritis Rheum"},{"key":"1231_CR19","first-page":"1821","volume":"27","author":"Thomas","year":"2000","unstructured":"Thomas E, Koumouvi K, Blotman F (2000) Impotence in a patient with rheumatoid arthritis treated with methotrexate. J Rheumatol 27(7):1821\u20131822","journal-title":"J Rheumatol"},{"key":"1231_CR20","first-page":"1793","volume":"29","author":"Aguirre","year":"2002","unstructured":"Aguirre MA, V\u00e9lez A, Romero M, Collantes E (2002) Gynecomastia and sexual impotence associated with methotrexate treatment. J Rheumatol 29(8):1793\u20131794","journal-title":"J Rheumatol"},{"key":"1231_CR21","first-page":"508","volume":"31","author":"Hong","year":"2004","unstructured":"Hong P, Pope JE, Ouimet JM et al (2004) Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis. J Rheumatol 31(3):508\u2013513","journal-title":"J Rheumatol"},{"key":"1231_CR22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/nau.20687","volume":"28","author":"Hanno","year":"2009","unstructured":"Hanno P, Dmochowski R (2009) Status of international consensus on interstitial cystitis\/bladder pain syndrome\/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 28(4):274\u2013286","journal-title":"Neurourol Urodyn"},{"key":"1231_CR23","doi-asserted-by":"crossref","unstructured":"Keller JJ, Liu SP, Lin HC (2012) A case-control study on the association between rheumatoid arthritis and bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn (im Druck) DOI 10.1002\/nau.22348","DOI":"10.1002\/nau.22348"},{"key":"1231_CR24","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.3899\/jrheum.120598","volume":"39","author":"Mahler","year":"2012","unstructured":"Mahler M, Parker T, Peebles CL et al (2012) Anti-DFS70\/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol 39(11):2104\u20132110","journal-title":"J Rheumatol"},{"key":"1231_CR25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00296-010-1782-x","volume":"32","author":"Emmungil","year":"2012","unstructured":"Emmungil H, Kalfa M, Zihni FY et al (2012) Interstitial cystitis: a rare manifestation of primary Sj\u00f6gren\u2019s syndrome, successfully treated with low dose cyclosporine. Rheumatol Int 32(5):1215\u20131218","journal-title":"Rheumatol Int"},{"key":"1231_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/aje\/kwr524","volume":"176","author":"Schenk","year":"2012","unstructured":"Schenk JM, Calip GS, Tangen CM et al (2012) Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 176(2):156\u2013163","journal-title":"Am J Epidemiol"},{"key":"1231_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1476-5381.2012.01969.x","volume":"167","author":"Altavilla","year":"2012","unstructured":"Altavilla D, Minutoli L, Polito F et al (2012) Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. Br J Pharmacol 167(1):95\u2013108","journal-title":"Br J Pharmacol"},{"key":"1231_CR28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1464-410X.2011.10867.x","volume":"110","author":"Sutcliffe","year":"2012","unstructured":"Sutcliffe S, Grubb Iii RL, Platz EA et al (2012) Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. BJU Int 110(7):1050\u20131059","journal-title":"BJU Int"},{"key":"1231_CR29","doi-asserted-by":"crossref","unstructured":"Mercer LK, Davies R, Galloway JB et al (2013) Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford) 52(1):91\u201398","DOI":"10.1093\/rheumatology\/kes350"},{"key":"1231_CR30","doi-asserted-by":"crossref","unstructured":"Orozco G, Goh CL, Al Olama AA et al (2013) Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. BJU Int. 111(17):1148\u20131155","DOI":"10.1111\/j.1464-410X.2012.11492.x"},{"key":"1231_CR31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s001200170003","volume":"40","author":"K\u00e4lble","year":"2001","unstructured":"K\u00e4lble T (2001) Etiopathology, risk factors, environmental influences and epidemiology of bladder cancer. Urologe A 40(6):447\u2013450","journal-title":"Urologe A"},{"key":"1231_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.25061","volume":"62","author":"Monach","year":"2010","unstructured":"Monach PA, Arnold LM, Merkel PA (2010) Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum 62(1):9\u201321","journal-title":"Arthritis Rheum"},{"key":"1231_CR33","doi-asserted-by":"crossref","unstructured":"Shih C, Hotaling JM, Wright JL, White E (2012) Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study. Urol Oncol (im Druck)","DOI":"10.1016\/j.juro.2011.02.908"},{"key":"1231_CR34","first-page":"S1078","volume":"pii","author":"Fairey","year":"2012","unstructured":"Fairey AS, Daneshmand S, Quinn D et al (2012) Neoadjuvant chemotherapy with gemcitabine\/cisplatin vs. methotrexate\/vinblastine\/doxorubicin\/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urol Oncol pii: S1078-1439(12)00247-5","journal-title":"Urol Oncol"},{"key":"1231_CR35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2310\/7750.2011.10078","volume":"15","author":"Kurian","year":"2011","unstructured":"Kurian A, Haber R (2011) Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature. J Cutan Med Surg 15(5):275\u2013279","journal-title":"J Cutan Med Surg"},{"key":"1231_CR36","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/j.1464-410X.2012.11079.x","volume":"110","author":"Lopez-Beltran","year":"2012","unstructured":"Lopez-Beltran A et al (2012) Lymphocytic vasculitis of the prostate transition zone. BJU Int 110(11):1775\u20131780","journal-title":"BJU Int"},{"key":"1231_CR37","doi-asserted-by":"crossref","first-page":"978396","DOI":"10.1155\/2012\/978396","volume":"2012","author":"Halilova","year":"2012","unstructured":"Halilova KI, Brown EE, Morgan SL, Bridges SL et al (2012) Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand? Int J Rheumatol 2012:978396. DOI 10.1155\/2012\/978396.","journal-title":"Int J Rheumatol"},{"key":"1231_CR38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4137\/CMAMD.S7773","volume":"4","author":"Hafez","year":"2011","unstructured":"Hafez EA, Mansour HE, Hamza SH et al (2011) Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 4:87\u201394","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"1231_CR39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)12713-4","volume":"361","author":"Gr\u00f6nberg","year":"2003","unstructured":"Gr\u00f6nberg H (2003) Prostate cancer epidemiology. Lancet 361(9360):859\u2013864","journal-title":"Lancet"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1231-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-013-1231-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1231-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T14:48:16Z","timestamp":1563634096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-013-1231-9"}},"subtitle":["Literatur\u00fcbersicht","Literature review"],"short-title":[],"issued":{"date-parts":[[2013,8,11]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1007\/s00393-013-1231-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718076916.793482328","asserted-by":"object"}]},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,11]]}}}